Logo AIDA

First Educational Session within the AIDA Project

We’re thrilled to share that our first educational session within the AIDA project, “Guidelines for management of patients with precancerous conditions and lesions in the stomach,” was a huge success!

We had the privilege of having Prof. Mário-Dinis Ribeiro from IPO Porto, Portugal as our esteemed presenter. With his extensive expertise in the field, he shared valuable insights on how to manage precancerous conditions and lesions in the stomach effectively.

Stay tuned for more updates on the AIDA EU project. We’re committed to ensuring you have the resources you need to make informed decisions and receive the best possible care.

Share

You might also be interested in

events

AIDA General Assembly Meeting 2025

On the 24th and 25th of March, the AIDA Consortium gathered in London for the AIDA General Assembly 2025. Hosted by Imperial College London, the two-day meeting brought together leading experts and project partners to discuss the latest advancements in AI-driven gastric cancer research. The assembly commenced with a warm welcome from INCLIVA and Imperial College London, setting the stage

news

AIDA Showcased at the Horizon Europe Conference in Oviedo

On 28 November 2024, AIDA was spotlighted at the 12th Horizon Europe Framework Programme Conference in Oviedo, Spain. Representing AIDA, Ana Miralles Marco, Project Manager of AIDA, participated in this prestigious event, presenting the project’s latest advancements in gastric cancer prevention. Organised by CDTI Innovación – Centro para el Desarrollo Tecnológico y la Innovación, in collaboration with the Ministry of

events

ENTERO 2024: AIDA Member DiCE Leads the Conversation on Early-Age Onset Digestive Cancers

One of our AIDA members, Digestive Cancers Europe (DiCE), successfully organised ENTERO 2024 in Porto, Portugal. A groundbreaking conference focused on the rising challenge of early-age onset digestive cancers. ENTERO 2024 shed light on the increasing prevalence of gastric, colorectal, pancreatic, and biliary tract cancers among younger populations. This growing trend has raised significant concerns within the medical and research